Corneal Collagen Crosslinking

CXL: Basics & Indications - Ectasia's Enemy

• Definition: Minimally invasive procedure; strengthens cornea by forming new collagen cross-links.

• Mechanism: Riboflavin (0.1% solution, Vit B2) + UVA light (365-370 nm, 3 mW/cm²) → photochemical reaction → ↑ corneal stiffness.

• Goal: Halt progression of corneal ectasias.

• Key Indications:

  • Progressive Keratoconus (KCN)
  • Pellucid Marginal Degeneration (PMD)
  • Post-refractive surgery (LASIK/PRK) ectasia
  • Infectious Keratitis (Pack-CXL, adjunctive)

• Contraindications (Epi-off):

  • Corneal thickness < 400 µm (critical threshold)
  • Active ocular infection (esp. herpetic)
  • Severe corneal scarring/opacity (obstructing visual axis)
  • Pregnancy/Lactation

⭐ CXL is most effective in progressive keratoconus, especially in younger patients with documented worsening of Kmax or astigmatism.

CXL: Mechanism & Protocols - UVA Superpowers

• Mechanism:

  • Riboflavin (Vit B2, photosensitizer) + UVA light (365-370 nm) → generates Reactive Oxygen Species (ROS), mainly singlet oxygen ($^1O_2$).
  • ROS create covalent bonds between collagen fibrils → ↑ corneal biomechanical strength.
  • Halts ectasia progression (e.g., keratoconus). 📌 Mnemonic "Dresden 3-30-5.4-400": 3 mW/cm², 30 min, 5.4 J/cm², 400 µm min thickness.

• Protocols:

  • Dresden (Standard Epi-off):
    • Epithelial debridement (8-9 mm).
    • Riboflavin 0.1% (iso-osmolar) instillation.
    • UVA: 3 mW/cm² for 30 min. Total energy: 5.4 J/cm².
    • Min. post-debridement stromal thickness: ≥400 µm.

    ⭐ Minimum corneal thickness of 400 µm (post-debridement) is critical to protect endothelium from UVA damage.

  • Accelerated CXL (Epi-off):
    • Higher irradiance, shorter time (e.g., 9 mW/cm² for 10 min; 18 mW/cm² for 5 min).
    • Maintains total energy: 5.4 J/cm² (Bunsen-Roscoe law).
  • Transepithelial (Epi-on):
    • Epithelium intact. Uses enhanced riboflavin formulations (e.g., with BAC, EDTA).
    • Less effective; for thinner corneas or faster recovery.

CXL: Pre & Post-Op Care - Beam Team Briefing

• Pre-Operative Evaluation:
  • Indications: Progressive keratoconus, post-LASIK ectasia.
  • Exclusion: Corneal thickness < 400 µm (epi-off).
  • Assessment: Topography (progression), pachymetry, slit-lamp.
  • Prep: Stop CL wear; counsel.
• Post-Operative Regimen (Epi-Off):
  • Immediate: Bandage contact lens (BCL), analgesics.
  • Medications:
    • Topical antibiotics (until epithelium heals + few days).
    • Topical steroids (post-epithelial healing, tapered).
    • Preservative-free artificial tears.
  • Follow-up: BCL removal (~5-7 days); serial topography.
  • Precautions: No eye rubbing, UV protection.
• Adverse Events & Outcomes:
  • Common: Pain, photophobia, transient haze, blurred vision.
  • Serious (Rare): Delayed healing, sterile infiltrates, infection, significant haze/scar, endothelial damage.
  • Failure: Continued progression.

⭐ Minimum corneal stromal thickness of 400 µm post-epithelial removal is crucial for epi-off CXL to protect the endothelium.

CXL: Outcomes & Efficacy - Vision Victorious?

• Primary Goal: Halt progression of keratoconus & other corneal ectasias.
• Efficacy:
  • Stabilizes ectasia in >90% of cases.
  • Corneal flattening (Kmax reduction): 1-2 D common; variable.
  • Visual Acuity: Often improves or stabilizes; Uncorrected (UCVA) & Best-corrected (BCVA) may ↑.
  • Refractive error: Myopic & astigmatic changes possible.
• Factors Influencing Outcomes:
  • Pre-op Kmax & corneal thickness.
  • Age (better in younger patients).
  • Technique (epi-on vs epi-off).
• Limitations: Not a refractive procedure primarily; vision improvement is a secondary benefit.

⭐ CXL typically leads to a reduction in maximum keratometry (Kmax) by 1-2 Diopters over 1-3 years, indicating corneal flattening and stabilization.

• Success Rate: High for arresting progression; less predictable for visual improvement alone.
• Duration of Effect: Long-term, potentially lifelong stabilization expected in most responsive cases.

High‑Yield Points - ⚡ Biggest Takeaways

• CXL strengthens cornea for progressive keratoconus & post-LASIK ectasia.
• Mechanism: Riboflavin (Vit B2) + UVA light (365nm) forms new collagen crosslinks.
• Goal: Halt progression, improve corneal biomechanical stability.
• Dresden Protocol: Epi-off, 0.1% riboflavin, 3mW/cm² UVA for 30 min.
• Safety: Min. stromal thickness 400µm post-epithelial removal.
• Outcomes: Halts progression, modest corneal flattening, VA stabilization/improvement.
• Avoid: Corneas <400µm, active herpetic keratitis, significant central scars.